Colchicine Versus Placebo in Acute Myocarditis Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT05855746
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 300 participants
- Registry
-
NCT05855746
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Recruiting
Technical summary
Registry record NCT05855746. Randomized; quadruple masking; primary purpose treatment. Start 2024-07-16 (actual); primary completion 2028-01-16 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine Versus Placebo in Acute Myocarditis Patients
- Acronym
- ARGO
- Condition
- Acute Myocarditis
- Intervention (Drug)
- Colchicine Pill
- Intervention (Drug)
- Placebo
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Collaborator
- Hospices Civils de Lyon
- Collaborator
- Fonds de Dotation ACTION
Record details
- Record id
cardio:ct-nct05855746- Content hash
54f011d39cc4f8d2b8930ecab9a5df093ccf8080e5c6dd9676ccf4cda4317ebf